SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high vehicle deliveries for December and the fourth quarter, significantly surpassing previous figures and nearing one million cumulative vehicles. This strong performance, further supported by extended EV subsidies in China, is driving considerable community discussion and optimism about the company's path to profitability and its competitive standing in the electric vehicle market.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc. is trending following news of a strategic manufacturing partnership set to scale production of its drug screening reader for anticipated U.S. market entry. The community is actively discussing the stock's massive volume and micro-float, fueling excitement for potential short-squeeze-like parabolic gains. However, a recent private placement with lower-priced warrants has sparked debate among traders, creating a highly volatile environment with divided opinions on its immediate future.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is currently trending amidst significant investor confusion and frustration surrounding a recent dividend event and persistent tracking discrepancies with its underlying asset, SMCI. The community is actively questioning the ETF's unusual behavior, with some alleging it's a "scam" or facing an imminent reverse split, while others view the current downturn as a potential buying opportunity despite concerns about leveraged product decay.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is currently a hot topic, with community discussion centering on the ongoing delay and mixed initial data for its inhaled cystic fibrosis therapy, ARCT-032, which showed some mucus plug reduction but not significant lung function improvements. Investors are closely monitoring an active trade secret lawsuit against AbbVie, generating widespread hope for a substantial settlement or potential acquisition. Many believe the company's advanced mRNA platform and solid cash runway make the stock deeply undervalued amidst significant short interest.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Crypto is trending after a recent price surge ignited a polarized community discussion. Supporters emphasize its real-world utility through Flexa's merchant network and anticipate significant growth with pending regulatory clarity and strategic partnerships. However, many investors express deep frustration, warning of sustained manipulation and a history of pump-and-dump cycles despite its technological foundations.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

SpaceX is trending due to widespread anticipation of a potential IPO in 2026, which is igniting significant speculative interest across the broader aerospace sector. Community discussions are heavily focused on identifying "SpaceX IPO plays," with companies like Momentus ($MNTS) gaining traction for its partnership on Falcon 9 missions and a notably low share count, sparking comparisons to past explosive meme stock surges.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust (GBTC) is trending amidst a fervent debate over Bitcoin's near-term price direction, with discussions highlighting recent ETF outflows and broader market dynamics. The community remains sharply divided, as many anticipate a "parabolic" rally for Bitcoin as a hedge against inflation, while others warn of an impending "crypto winter" and significant price corrections based on historical cycles and perceived lack of intrinsic value.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending amid intense community discussion following recent developments, including a partial summary judgment in its ongoing litigation and strategic changes to its executive team, which are fueling heightened speculation around a potential acquisition. Investors are closely monitoring progress for its rare disease therapy, MIPLYFFA, toward European market access and a patent term extension, while broadly criticizing management for perceived undervaluation and executive compensation. Despite these concerns, many maintain a bullish outlook, citing the company's significant cash reserves and pipeline assets as indicators of untapped value.

iShares Ethereum Trust (The) - Undivided Beneficial Interest

iShares Ethereum Trust ETF

iShares Ethereum Trust ETF ($ETHA) is trending amidst strong speculation surrounding spot Ethereum ETF approvals, particularly those offering staking, which is expected to drive institutional demand. The recent "Fusaka Upgrade" is also a key talking point, with its impact on Ethereum's burn rate fueling bullish outlooks and active options trading. While many investors are actively 'buying the dip' and positioning for a potential decoupling from Bitcoin, others maintain caution regarding crypto market volatility.

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is generating significant buzz after the FDA accepted its Biologics License Application for Veligrotug, granting Priority Review for Thyroid Eye Disease and setting a PDUFA target. The community is widely discussing Veligrotug's potential as a best-in-class treatment, citing its strong efficacy across both active and chronic TED compared to current therapies, which fuels analyst upgrades and M&A speculation for the company's innovative pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mining Stocks To Follow Today - December 31st

IREN, Caterpillar, First Majestic Silver, MP Materials, Newmont, Freeport-McMoRan, and Barrick Mining are the seven Mining stocks to watch today, according to MarketBeat's stock screener tool. Mining...

Promising Gold Stocks To Consider - December 31st

First Majestic Silver, Newmont, Freeport-McMoRan, Barrick Mining, and Hecla Mining are the five Gold stocks to watch today, according to MarketBeat's stock screener tool. Gold stocks are shares of...

AG February 2026 Options Begin Trading

Investors in First Majestic Silver Corp (Symbol: AG) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...

<ul class="summary-bullets"><li>In its notice, CME said the increase was “per the normal review of market volatility.”</li><li>Silver has climbed nearly 150% this year, and is on track to post its best yearly percentage gains since 1979.</li><li>Spot gold prices have jumped 65% this year.</li></ul>Silver prices fell by more than 5% on Wednesday after CME Group raised margins on precious-metal futures for the second time in less than a week, following a period of volatile trading.Silver futures for March 2026 deliveries crashed over 8% to $75.1 per ounce, while spot prices (XAG/USD) slid 6% to $71.4 per ounce.Exchanges often raise margin requirements following sharp price moves in commodities or securities. In its notice, CME said the increase was “per the normal review of market volatility.”<h2 class="st-heading-2">Silver’s Historic Run In 2025</h2>Despite a tumultuous week that saw spot prices decline by&nbsp;more 15% an ounce, silver recorded a historic run in 2025, climbing nearly 150%. It is on track to post its best yearly percentage gains since 1979. Spot prices had closed at $24.9 per ounce on Dec. 31, 2024.Silver demand has climbed as industrial use accelerates, driven by rising adoption in solar panels and electric vehicles, raising concerns that supply may struggle to keep up. Demand has also been supported by uncertainty around the dollar following the Fed’s rate cut. In addition, silver has benefited from its designation as a critical U.S. mineral, ongoing supply constraints, and historically low inventories.<h2 class="st-heading-2">Gold Eases From Record Highs</h2>Gold has also logged a historic year, with bullion on pace for its biggest annual gain since 1979. Spot prices climbed to a record $4,550 an ounce on Friday but have since pulled back.The XAU/USD pair was down about 0.5% at $4,315 an ounce, while February 2026 futures declined 1.4% to $4,326.1 per ounce.Earlier this month, Morgan Stanley said it expects gold’s gains to moderate in 2026 as central banks and ETFs slow their buying, though rate cuts and a weaker dollar should continue to support prices.<h2 class="st-heading-2">ETF Watch</h2>The iShares Silver Trust (SLV) was down 5.5% in premarket trading and among the top-trending tickers on Stocktwits.Despite the intraday decline, retail sentiment on the platform remained ‘extremely bullish’ over the past 24 hours, amid ‘extremely high’ message volumes.Year-to-date, <a href="https://stocktwits.com/symbol/SLV">SLV</a> has gained nearly 160%.Miners <a href="https://stocktwits.com/symbol/HL">Hecla Mining Co</a>. (HL) was down 3.2%,&nbsp;<a href="https://stocktwits.com/symbol/AG">First Majestic Silver Corp</a>. (AG) traded 3% lower, while&nbsp;<a href="https://stocktwits.com/symbol/PAAS">Pan American Silver Corp.</a> (PAAS) tumbled 2.6% in premarket trading.&nbsp;Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/axsome-advances-toward-fda-filing-for-drug-to-treat-narcolepsy/cL7B4KPREzL">Axsome Advances Toward FDA Filing For Drug To Treat Narcolepsy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bavaria, Munich: Gold and silver bars of various sizes lie in a safe on a table at the precious metals dealer Pro Aurum. 

Silver Slipped 5% Today But Is Poised For Biggest Annual Gain in 46 Years

The decline comes after CME Group raised margins on precious-metal futures for the second time in less than a week.

Equity

The Zacks Analyst Blog Highlights First Majestic Silver, Agnico Eagle Mines, Kinross Gold and Fortuna Mining

First Majestic Silver has surged more than 200% in a year, fueled by portfolio moves, strong production growth and soaring silver prices.

First Majestic Silver (TSE:AG) Stock Price Up 1.4% - What's Next?

First Majestic Silver (TSE:AG) Trading 1.4% Higher - Should You Buy...

Gold Stocks To Watch Today - December 30th

Newmont, Freeport-McMoRan, and First Majestic Silver are the three Gold stocks to watch today, according to MarketBeat's stock screener tool. Gold stocks are shares of companies involved in the...

AG Stock Soars 205% in a Year: What's Aiding Its Performance?

First Majestic surges 205% in a year, fueled by asset sales, the Gatos Silver acquisition, record Q3 results and a powerful increase in silver prices.

Coeur Mining or First Majestic: Which Miner Offers Better Value? 

CDE and AG are benefiting from higher gold and silver prices as strong Q3 production, rising cash flow and balance sheet gains fuel momentum. 

First Majestic Silver Corp. $AG Stock Holdings Lessened by Vontobel Holding Ltd.

Vontobel Holding Ltd. cut its stake in shares of First Majestic Silver Corp. (NYSE:AG - Free Report) (TSE:FR) by 73.5% in the 3rd quarter, according to the company in its most recent 13F filing with...

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

AG
First Majestic Silver Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AG News

AGFirst Majestic Silver Corporation